✦ LIBER ✦

Reply to the research mission in myeloma by Richardson et al.

✍ Scribed by Bergsagel, P L

Book ID: 109886570
Publisher: Nature Publishing Group
Year: 2008
Tongue: English
Weight: 66 KB
Volume: 23
Category: Article
ISSN: 0887-6924
DOI: 10.1038/leu.2008.211

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The research mission in myeloma

✍ Richardson, P G; San-Miguel, J; Lonial, S; Reece, D; Jakubowiak, A; Hussein, M; 📂 Article 📅 2008 🏛 Nature Publishing Group 🌐 English ⚖ 63 KB

Reply to ‘Rituximab in CD20 positive mul

Reply to ‘Rituximab in CD20 positive multiple myeloma’ by P Moreau et al.

✍ Greipp, P T; Kapoor, P; Morice, W G; Witzig, T E; Greipp, P R 📂 Article 📅 2007 🏛 Nature Publishing Group 🌐 English ⚖ 141 KB

In reply to the letter by Gevaert et al.

✍ Jozien Helleman; Maurice P.H.M. Jansen; Maria E.L. van der Burg; Els M.J.J. Bern 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 French ⚖ 40 KB

raised an important issue about the implementation in clinical practice of the 9-gene set for platinum resistance of ovarian cancer patients. They also stated that nonplatinum containing regimens are suboptimal in the treatment of ovarian cancer. In our study 1 we have included specimens of 96 prim

In response to the reply by Roach et al.

✍ Howard M. Sandler; Ronald W. McCallum 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 332 KB

Reply to the letter by MacLeod et al.

✍ Hisashi Kubota; Takafumi Nishizaki; Kohsuke Sasaki 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 28 KB

We are grateful to Dr. MacLeod and his colleagues for raising this important suggestion. As they commented, in several cases it is not possible to rule out accidental inclusion of syngeneic subclones in the analysis due to cell line cross-contamination. Therefore, such cell line cross-contamination

Reply to the comment by Skrobik et al.

✍ Sophia de Rooij; Evert de Jonge 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 79 KB